The pneumococcal vaccine market is expected to show considerable growth at a CAGR of around 4.0% during the forecast period 2020-2026. Major factors for the growth of the market include high spending to curb pneumonia among children in the developed economies. Moreover, increasing healthcare infrastructure in the emerging economies, rising per capita healthcare expenditure, and growing awareness toward vaccination are also augmenting the market growth. In addition, innovations in the pneumonia vaccines are also providing significant opportunities to the market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market
As per a report by John Hopkins, around 5.7 million children were died before attaining the age of 5 years in 2016 out of which nearly 25% were due to pneumonia or diarrhea. 15 countries, mainly in Asia and Africa have the most burden of pneumonia. As in 2018, 55% of the global under 5-year age population resides in these countries however they represent 70% of the global under-5 pneumonia and diarrhea deaths. The countries include China, India, Indonesia, Nigeria, Pakistan, the Democratic Republic of the Congo, Ethiopia, Chad, Angola, Somalia, Tanzania, Niger, Bangladesh, Uganda, and Côte d’Ivoire. Growth in the private healthcare expenditure in the emerging economies such as India, China, and Indonesia, and increasing investment by government and international organizations will provide a significant opportunity to the market.
A full report of Global Pneumococcal Vaccine Market available @ https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Pneumococcal Vaccine Market by Vaccine Type
- Pneumococcal Conjugate Vaccine (PCV13)
- Pneumococcal Polysaccharide Vaccine (PPSV23)
- Other
Global Pneumococcal Vaccine Market by Distribution Channel
- Public (Government & Non-Government)
- Private
Global Pneumococcal Vaccine Market by Type
- Branded
- Generic
Global Pneumococcal Vaccine Market by Age Group
- Children
- Adult
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Astellas Pharma Inc.
- China National Biotec Group Company Ltd.
- CSL Ltd.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novavax, Inc.
- Pfizer Inc.
- Walvax Biotechnology Co., Ltd.
- SK Bioscience
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- PnuVax Incorporated
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Pneumococcal vaccine market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
